HIGHER ENDOSCOPIC AND CLINICAL REMISSION RATES WITH VEDOLIZUMAB IN EARLY THAN IN LATE CROHN’S DISEASE: RESULTS FROM THE LOVE-CD STUDY (LOW COUNTRIES VEDOLIZUMAB IN CD STUDY)

Geert R. D'Haens  ¹     Peter Bossuyt  ²     Filip Baert  ³     Tamás Molnár  ⁴     Wouter Van Moerkercke  ⁵     Esmee Clasquin  ⁵     Mark Lowenberg  ⁶     Nahid Mostafavi  ⁶     Harald Peeters  ⁷     Guy Lambrecht  ⁸     Frank Hoentjen  ⁹     Severine Vermeire  ^10    
1 Amsterdam University Medical Centers, Amsterdam, Netherlands
² Imelda General Hospital, Bonheiden, Belgium
³ Az Delta, Roeselare, Belgium
⁴ University Of Szeged, Szeged, Hungary
⁵ AZ Groeninge, Kortrijk, Belarus
⁶ Amsterdam University Medical Center, Amsterdam, Netherlands
⁷ St Lukas Hospital, Gent, Belgium
⁸ MSD, Oostende, Belgium
⁹ Radboud University Medical Center, Nijmegen, Netherlands
¹⁰ University Hospital Leuven, Leuven, Belgium

Topic
IBD, Nurses, Primary Care

Session
Clinical trials in Crohn's disease

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)